Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110313344 | 11031334 | 4 | F | 20160229 | 20160908 | 20150415 | 20160914 | PER | US-PFIZER INC-2015127083 | PFIZER | 76.00 | YR | F | Y | 68.27000 | KG | 20160914 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110313344 | 11031334 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | UNK | N | 21446 | CAPSULE, HARD | ||||||||
| 110313344 | 11031334 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 75 MG, 2X/DAY | N | M83431 | 21446 | 75 | MG | CAPSULE, HARD | BID | ||||
| 110313344 | 11031334 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 75 MG, 1X/DAY | N | M83431 | 21446 | 75 | MG | CAPSULE, HARD | QD | ||||
| 110313344 | 11031334 | 4 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 110313344 | 11031334 | 5 | C | MOBIC | MELOXICAM | 1 | 50 MG, 1X/DAY | 0 | 50 | MG | TABLET | QD | |||||||
| 110313344 | 11031334 | 6 | C | MELOXICAM. | MELOXICAM | 1 | 15 MG, 1X/DAY | 0 | 15 | MG | TABLET | QD | |||||||
| 110313344 | 11031334 | 7 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 75 UG, 1X/DAY | 0 | 75 | UG | TABLET | QD | |||||||
| 110313344 | 11031334 | 8 | C | DULOXETINE DRLA | 2 | 30 MG, 1X/DAY, (IN THE MORNING) | 0 | 30 | MG | CAPSULE | QD | ||||||||
| 110313344 | 11031334 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG, 1X/DAY | 0 | 20 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110313344 | 11031334 | 1 | Fibromyalgia |
| 110313344 | 11031334 | 2 | Neuropathy peripheral |
| 110313344 | 11031334 | 3 | Post herpetic neuralgia |
| 110313344 | 11031334 | 4 | Pain |
| 110313344 | 11031334 | 5 | Arthritis |
| 110313344 | 11031334 | 6 | Arthritis |
| 110313344 | 11031334 | 7 | Thyroid disorder |
| 110313344 | 11031334 | 8 | Pain |
| 110313344 | 11031334 | 9 | Abdominal discomfort |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110313344 | 11031334 | Arthralgia | |
| 110313344 | 11031334 | Breast pain | |
| 110313344 | 11031334 | Gait disturbance | |
| 110313344 | 11031334 | Glucose tolerance impaired | |
| 110313344 | 11031334 | Herpes zoster | |
| 110313344 | 11031334 | Insomnia | |
| 110313344 | 11031334 | Intentional product use issue | |
| 110313344 | 11031334 | Neuralgia | |
| 110313344 | 11031334 | Neuropathy peripheral | |
| 110313344 | 11031334 | Pain | |
| 110313344 | 11031334 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |